Wednesday, December 25, 2013
Merry Christmas!
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Tuesday, December 24, 2013
Report: Christmas will kill you | National Monitor
Christmas in the post-War United States (Photo credit: Wikipedia) |
"According to a Medical Daily report, the most common causes of death during Christmas and extending to the New Year are cardiac disease, respiratory diseases, endocrine/nutritional/metabolic problems, digestive diseases, and cancer."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
We Moved Forward on Many Fronts This Year | FDA Voice
Commisioner of the United States Food and Drug Administration Margaret Hamburg. (Photo credit: Wikipedia) |
"All of us take great pride in the skill and vigor with which we overcame the year’s challenges and new demands. And so, as the year draws to a close, I extend my gratitude to the employees at the FDA who work tirelessly on behalf of the American public year in and year out. To all of our stakeholders, my heartfelt wishes for a joyous holiday season and a safe and healthy 2014.
Margaret A. Hamburg, M.D., is the Commissioner of the Food and Drug Administration"
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Labels:
2013,
fda,
Hamburg,
Margaret Hamburg
Thursday, December 19, 2013
Expert Panel Want BP Cuffs Loosened - MedPage Today
Updated July 5, 2024
The original link broke.
You might also like:
--- the original post follows below ---
"For most hypertensive individuals 60 or older, pharmacologic treatment should be started when the systolic pressure is 150 mm Hg or higher or the diastolic pressure is 90 mm Hg or higher, with the goal of achieving readings below those cutoffs, according to the new recommendations."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Labels:
blood pressure,
fda,
gmp,
guidelines,
qsr,
training,
treatment
Thursday, December 5, 2013
FDA Drug Quality and Security Act Stakeholder Discussion Notes - No Bullwhip
Updated October 24, 2022
The original link broke.
You can still read about the same topic here:
--- the original post follows below ---
"The FDA held its first public stakeholder call this morning (Dec. 3rd, 2013) to discuss the new Drug Quality and Security Act law. This is the first of a series of public engagements that the FDA will hold as the various provisions of DQSA are phased in starting Jan. 1, 2015 and continuing over the next 10 years.
The call, led by Dr. Ilisa Bernstein and Cara Tenenbaum of the FDA, didn't contain much in the way of hard specifics on rules, regulations and licensure. The FDA is still developing its go-forward plans and communication processes."
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Tuesday, December 3, 2013
Procedure Writing Course
483 Observation Gotchas!
1. Firm's procedures lack sufficient detail.
2. Employees perform significant steps not included in procedures.
3. Firm lacks procedures for a variety of production, maintenance, and quality assurance activities.
Plan Your Training!
- Does your company constantly update and revise procedures, or
- Are procedures the root cause of many deviations, or
- Are procedures ignored, being replaced by word-of-mouth guidance from colleagues?
If you answered "Yes" to one or more of these questions, then you need to take a look at our Writing Standard Operating Procedures workshop.
Featured Course
Writing Procedures: This course is as much about consulting as training. In this course, Allan reviews and consults on a firm's procedure for writing procedures, and then coaches employees on procedure writing. Employees work with existing or needed procedures in this workshop.
Tools addressed in this very popular workshop:
1. Readability analysis
1. Readability analysis
2. Task analysis
3. Decision-making through procedures
4. Determining the appropriate level of detail
5. Task grouping for greater comprehension
6. Procedure reviews and more!
If your firm is not satisfied with the quality of procedures, then you need to look into our Writing Procedures workshop!
Allan Dewes, President.
|
About Your Instructor
Allan Dewes
Allan Dewes has worked on writing procedures and training others to write procedures for over 30 years. Allan understands CGMP regulations, the FDA expectations, and how to make procedures easy to write and understand.
Call Today!
SkillsPlus International Inc.
(415) 948-5220
(415) 948-5220
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Monday, December 2, 2013
Nanotech Roundup: Latest National Nanotechnology Initiative Strategic Plan Released for Comment - FDA Law Blog
"The draft plan lays out the NNI’s goals and objectives, which remain largely unchanged from 2011 (see here). As with the 2011 Plan, the draft 2014 Plan includes a description of FDA’s NNI-related activities. Those activities continue to be primarily focused on the goal of supporting responsible development of nanotechnology. However, the 2014 Plan more explicitly recognizes the potential impact of nanotechnology on the status of FDA-regulated products:" . . .
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Labels:
fda,
nano,
nanotechnology,
NNI,
plan,
technology
Subscribe to:
Posts (Atom)